Matches in SemOpenAlex for { <https://semopenalex.org/work/W4252156907> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4252156907 endingPage "711" @default.
- W4252156907 startingPage "700" @default.
- W4252156907 abstract "Based on in vitro data suggesting that recombinant human granulocyte- macrophage colony-stimulating factor (rhGM-CSF) is capable of stimulating acute myeloid leukemia (AML) blast cells to become more sensitive to cell-cycle-specific drugs we conducted a phase I/II study in de novo AML patients (pts). rhGM-CSF (250 micrograms/m2/d, continuous intravenous infusion) was administered in 18 pts suffering from de novo AML in combination with standard induction chemotherapy (3 + 7 = daunorubicin 45 mg/m2 days 1 through 3, cytosine-arabinoside [Ara- C] 200 mg/m2 continuous infusion days 1 through 7). GM-CSF was started 48 or 24 hours before chemotherapy (prephase) in 14 pts. In four pts with high white blood cell counts (WBC) rhGM-CSF was started after chemotherapy-induced cell reduction (WBC less than 30,000/mm3). During prephase GM-CSF induced an increase in neutrophil and blast cell counts in 13 of 14 and 10 of 14 pts, respectively. In vivo recruitment of leukemic cells into drug-sensitive phases of the cell cycle could be demonstrated by multiparameter cell-cycle analyses in peripheral blood (n = 7) and bone marrow (n = 4) specimens. On day 14, complete aplasia was evident in 17 of 18 pts. GM-CSF was administered until recovery from chemotherapy-induced myelosuppression (absolute neutrophil counts, [ANC] greater than 500/mm3). Fifteen pts (83%) achieved complete remission, 12 did so with one cycle. A shorter duration of neutropenia was evident in these pts compared with historical controls (n = 39), (ANC greater than 500/mm3, day 22.5 +/- 3.4 v 25.2 +/- 3.7, P less than .05). Three pts achieved complete remission after a second cycle (same combination of rhGM-CSF and 3 + 7). Two pts died during bone marrow aplasia because of invasive pulmonary aspergillosis. Clinical side effects possibly related to GM-CSF, mainly fever, diarrhea, and weight gain were mild and tolerable (World Health Organization toxicity grade less than or equal to 2). Together, rhGM-CSF recruits kinetically quiescient AML cells in vivo to enter drug-sensitive phases of the cell cycle and promotes early myeloid recovery from aplasia after exposure to standard induction chemotherapy for AML." @default.
- W4252156907 created "2022-05-12" @default.
- W4252156907 creator A5000262370 @default.
- W4252156907 creator A5004289282 @default.
- W4252156907 creator A5006306448 @default.
- W4252156907 creator A5010063260 @default.
- W4252156907 creator A5032110869 @default.
- W4252156907 creator A5044003137 @default.
- W4252156907 creator A5052576704 @default.
- W4252156907 creator A5053537794 @default.
- W4252156907 creator A5073111010 @default.
- W4252156907 creator A5079262854 @default.
- W4252156907 date "1991-02-15" @default.
- W4252156907 modified "2023-09-27" @default.
- W4252156907 title "Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia" @default.
- W4252156907 doi "https://doi.org/10.1182/blood.v77.4.700.bloodjournal774700" @default.
- W4252156907 hasPublicationYear "1991" @default.
- W4252156907 type Work @default.
- W4252156907 citedByCount "1" @default.
- W4252156907 crossrefType "journal-article" @default.
- W4252156907 hasAuthorship W4252156907A5000262370 @default.
- W4252156907 hasAuthorship W4252156907A5004289282 @default.
- W4252156907 hasAuthorship W4252156907A5006306448 @default.
- W4252156907 hasAuthorship W4252156907A5010063260 @default.
- W4252156907 hasAuthorship W4252156907A5032110869 @default.
- W4252156907 hasAuthorship W4252156907A5044003137 @default.
- W4252156907 hasAuthorship W4252156907A5052576704 @default.
- W4252156907 hasAuthorship W4252156907A5053537794 @default.
- W4252156907 hasAuthorship W4252156907A5073111010 @default.
- W4252156907 hasAuthorship W4252156907A5079262854 @default.
- W4252156907 hasBestOaLocation W42521569071 @default.
- W4252156907 hasConcept C126322002 @default.
- W4252156907 hasConcept C203014093 @default.
- W4252156907 hasConcept C2776694085 @default.
- W4252156907 hasConcept C2777063308 @default.
- W4252156907 hasConcept C2777478134 @default.
- W4252156907 hasConcept C2777767877 @default.
- W4252156907 hasConcept C2778041864 @default.
- W4252156907 hasConcept C2778488018 @default.
- W4252156907 hasConcept C2778690821 @default.
- W4252156907 hasConcept C2778729363 @default.
- W4252156907 hasConcept C2779282312 @default.
- W4252156907 hasConcept C2780007613 @default.
- W4252156907 hasConcept C2781021840 @default.
- W4252156907 hasConcept C71924100 @default.
- W4252156907 hasConcept C74133956 @default.
- W4252156907 hasConcept C98274493 @default.
- W4252156907 hasConceptScore W4252156907C126322002 @default.
- W4252156907 hasConceptScore W4252156907C203014093 @default.
- W4252156907 hasConceptScore W4252156907C2776694085 @default.
- W4252156907 hasConceptScore W4252156907C2777063308 @default.
- W4252156907 hasConceptScore W4252156907C2777478134 @default.
- W4252156907 hasConceptScore W4252156907C2777767877 @default.
- W4252156907 hasConceptScore W4252156907C2778041864 @default.
- W4252156907 hasConceptScore W4252156907C2778488018 @default.
- W4252156907 hasConceptScore W4252156907C2778690821 @default.
- W4252156907 hasConceptScore W4252156907C2778729363 @default.
- W4252156907 hasConceptScore W4252156907C2779282312 @default.
- W4252156907 hasConceptScore W4252156907C2780007613 @default.
- W4252156907 hasConceptScore W4252156907C2781021840 @default.
- W4252156907 hasConceptScore W4252156907C71924100 @default.
- W4252156907 hasConceptScore W4252156907C74133956 @default.
- W4252156907 hasConceptScore W4252156907C98274493 @default.
- W4252156907 hasIssue "4" @default.
- W4252156907 hasLocation W42521569071 @default.
- W4252156907 hasOpenAccess W4252156907 @default.
- W4252156907 hasPrimaryLocation W42521569071 @default.
- W4252156907 hasRelatedWork W1187331240 @default.
- W4252156907 hasRelatedWork W1975423524 @default.
- W4252156907 hasRelatedWork W1997190408 @default.
- W4252156907 hasRelatedWork W1999706042 @default.
- W4252156907 hasRelatedWork W2017298652 @default.
- W4252156907 hasRelatedWork W2120457371 @default.
- W4252156907 hasRelatedWork W2374626322 @default.
- W4252156907 hasRelatedWork W2404892170 @default.
- W4252156907 hasRelatedWork W2409110410 @default.
- W4252156907 hasRelatedWork W2472158911 @default.
- W4252156907 hasVolume "77" @default.
- W4252156907 isParatext "false" @default.
- W4252156907 isRetracted "false" @default.
- W4252156907 workType "article" @default.